Upgrade naar
Pro
Log in / Registreer
Toggle navigation
Menu
Home
Koersen
Rendementen
Nieuws
Adviezen
Ratings
Sectoren
Analyses
Rapporten
Insiders
Short
Research
Mijn portefeuilles
Nieuws
Videos
Podcasts
Outlooks
Hot Topics
Bedrijven
Sectoren
Screeners
Research
Econ. nieuws
Short sell
Universiteit
Home
Bedrijven
iovera Wins Good Design Award
iovera Wins Good Design Award
7 januari 2014
REDWOOD CITY, Calif., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Myoscience is pleased to announce that the iovera°(®) system has won in the medical category of the GOOD DESIGN(TM) competition. GOOD DESIGN recognizes the world's most important consumer design products and is one of the most prestigious and oldest design awards. The awards are organized annually by The Chicago Athenaeum Museum of Architecture and Design in cooperation with the European Centre for Architecture, Art, Design and Urban Studies. Over 700 new products and graphic designs were selected from more than 38 countries for categories including electronics, robotics, children's products and transportation. The winning entries were awarded for innovation in a variety of areas such as sustainability, creativity, human impact, technology and universal design. The iovera° system, developed by myoscience, inc. harnesses the power of cold using Focused Cold Therapy(TM), the advanced technology that powers the device. The iovera° treatment works immediately for both health and beauty applications without leaving any toxins or chemicals behind in the body. The iovera° system is approved in the European Union and Canada for the treatment of wrinkles, and is FDA cleared for the treatment of pain in the United States. "The iovera° system was designed to change the way that physicians address the temporary treatment for pain and wrinkles," says myoscience CEO Clint Carnell. "The Focused Cold Therapy technology enables physicians to treat using only the power of cold delivered with a simple and intuitive one-button device. The engineers and designers at LUNAR worked hard in collaboration with the myoscience team to ensure we created a beautiful and effective product." This is the second design award for the iovera° system, following on the heels of the Spark! Design award, where the iovera° system received the highest honors in the general consumer design category. To see the full list of awards: http://www.chi-athenaeum.org/gdesign/2013/GOOD_DESIGN_2013_MASTER-list.pdf To see the press release from GOOD DESIGN: http://www.chi-athenaeum.org/gdesign/2013/GOOD_DESIGN_2013_PRESS_INFO.pdf ABOUT THE GOOD DESIGN(TM) AWARD GOOD DESIGN(TM) is the world's most prestigious, recognized, and oldest Design Awards program organized annually by The Chicago Athenaeum Museum of Architecture and Design in cooperation with the European Centre for Architecture, Art, Design and Urban Studies. GOOD DESIGN covers new consumer products designed and manufactured in Europe, Asia, Africa, and North and South America. http://www.chi-athenaeum.org/gdesign/index.html ABOUT MYOSCIENCE Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold Therapy(TM), the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the technology underlying the iovera° treatment, which is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. The iovera° system has also been cleared in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com. © 2013 myoscience. All rights reserved. iovera° and Focused Cold Therapy are trademarks of myoscience. CONTACT: MEDIA RELATIONS Johanna Beckmen / mediarelations@myoscience.com This announcement is distributed by GlobeNewswire on behalf of GlobeNewswire clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: myoscience via GlobeNewswire [HUG#1752982]
Overig beursnieuws
07:54
Wall Street blijft optimistisch ondanks hawkishe uitspraken Fed
08:22
ETF van de week: iShares China Large Cap UCITS ETF (FXC)
07:58
Japanse yen bereikt laagste niveau in 34 jaar
Abonneren op onze nieuwsbrief
Schrijf u gratis in voor ons beleggingsplatform met alles over aandelen, opties en ETF's. Meer dan 100.000 beleggers gingen u al voor.
If you are a human, ignore this field
Outlooks
Donderdag cijfers VS o.a. Ferrellgas Partners LP en Park City Group Inc
Donderdag EU-cijfers o.a. abrdn Property Income Trust Ltd en Enwell Energy PLC
Woensdag cijfers VS o.a. H.B. Fuller Company en Migom Global Corp
Tweets by @Analistbe
Duitse aandelenbeurs
Economische ontwikkelingen
5 redenen om bij LYNX te beleggen
Kies de beste broker